Relapsed plasmablastic lymphoma in a HIV-negative patient: Pushing the envelope

被引:5
作者
Kathrotiya, Manthan [1 ]
Radhakrishnan, Vivek S. [1 ]
Bhave, Saurabh J. [1 ]
Kumar, Jeevan [1 ]
Roychowdhury, Mita [1 ]
Arun, Indu [2 ]
Das, Jayanta [3 ]
Chandy, Mammen [1 ]
Nair, Reena [1 ]
机构
[1] Tata Med Ctr, Clin Haematol Oncol & HCT, 14,MAR EW, Kolkata, WB, India
[2] Tata Med Ctr, Pathol, Kolkata, India
[3] Tata Med Ctr, Nucl Med, Kolkata, India
关键词
daratumumab; haploidentical transplantation; novel therapies; plasmablastic lymphoma; relapse; STEM-CELL TRANSPLANTATION; AIDS;
D O I
10.1002/ccr3.3673
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV-negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.
引用
收藏
页码:873 / 877
页数:5
相关论文
共 15 条
[1]   Hematopoietic Cell Transplantation for Plasmablastic Lymphoma: A Review [J].
Al-Malki, Monzr M. ;
Castillo, Jorge J. ;
Sloan, J. Mark ;
Re, Alessandro .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (12) :1877-1884
[2]   Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma [J].
Castillo, Jorge J. ;
Guerrero-Garcia, Thomas ;
Baldini, Francesco ;
Tchernonog, Emmanuelle ;
Cartron, Guillaume ;
Ninkovic, Slavisa ;
Cwynarski, Kate ;
Dierickx, Daan ;
Tousseyn, Thomas ;
Lansigan, Frederick ;
Linnik, Yevgeny ;
Mogollon, Renzo ;
Navarro, Jose-Tomas ;
Olszewski, Adam J. ;
Reagan, John L. ;
Fedele, Pasquale ;
Gilbertson, Michael ;
Grigoriadis, George ;
Bibas, Michele .
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (04) :679-682
[3]   Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma [J].
Castillo, Jorge J. ;
Winer, Eric S. ;
Stachurski, Dariusz ;
Perez, Kimberly ;
Jabbour, Melhem ;
Milani, Cannon ;
Colvin, Gerald ;
Butera, James N. .
LEUKEMIA & LYMPHOMA, 2010, 51 (11) :2047-2053
[4]  
Chikeka Ijeuru, 2020, JAAD Case Rep, V6, P161, DOI 10.1016/j.jdcr.2019.11.007
[5]   Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we can [J].
Hamadani, Mehdi ;
Devine, Steven M. .
BLOOD, 2009, 114 (12) :2564-2566
[6]   Plasmablastic microlymphoma arising in human herpesvirus-8-associated multicentric Castleman disease in a human immunodeficiency virus-seronegative patient with clinical response to anti-interleukin-6 therapy [J].
Koenig, Gabriel ;
Stevens, Todd M. ;
Peker, Deniz .
HISTOPATHOLOGY, 2015, 67 (06) :930-932
[7]   Plasmablastic lymphoma: current perspectives [J].
Lopez, Andres ;
Abrisqueta, Pau .
BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2018, 8 :63-69
[8]   Clinicopathologic Comparison of Plasmablastic Lymphoma in HIV-positive, Immunocompetent, and Posttransplant Patients Single-center Series of 25 Cases and Meta-analysis of 277 Reported Cases [J].
Morscio, Julie ;
Dierickx, Daan ;
Nijs, Jan ;
Verhoef, Gregor ;
Bittoun, Emilie ;
Vanoeteren, Xanne ;
Wlodarska, Iwona ;
Sagaert, Xavier ;
Tousseyn, Thomas .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (07) :875-886
[9]   Refractory plasmablastic lymphoma-a review of treatment options beyond standard therapy [J].
Pretscher, Dominik ;
Kalisch, Alexander ;
Wilhelm, Martin ;
Birkmann, Josef .
ANNALS OF HEMATOLOGY, 2017, 96 (06) :967-970
[10]   Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base [J].
Qunaj, Lindor ;
Castillo, Jorge J. ;
Olszewski, Adam J. .
LEUKEMIA & LYMPHOMA, 2018, 59 (06) :1375-1383